Clinical Trial Update: Brain Radiotherapy Combined With Dalpiciclib and Endocrine Therapy in HR-Positive/HER2-Negative Advanced Breast Cancer With Brain Metastases [Phase 2]

View source ↗

Summary

A Phase 2 clinical trial evaluating brain radiotherapy combined with dalpiciclib and endocrine therapy for HR-positive/HER2-negative advanced breast cancer with…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Brain Metastases
• Breast Cancer
• Hr-positive Breast Cancer

Drugs mentioned

• Dalpiciclib (dalpiciclib)
• Endocrine therapy

Snippet

Sponsor: Nanfang Hospital, Southern Medical University | Conditions: Breast Cancer, Brain Metastases | Phase 2 | Status: NOT_YET_RECRUITING